You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Medtronic
Johnson and Johnson
AstraZeneca
Colorcon

Last Updated: February 23, 2024

CLINICAL TRIALS PROFILE FOR NEBIVOLOL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Nebivolol Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00125853 ↗ The Effect of Nebivolol on Insulin Sensitivity Completed Foundation for Circulatory Health N/A 2006-07-01 The purpose of this study is to conduct a randomised trial to compare the insulin sensitivity, 24 hour blood pressure profile, and tolerability of nebivolol plus a thiazide-like diuretic versus atenolol plus a thiazide-like diuretic.
NCT00125853 ↗ The Effect of Nebivolol on Insulin Sensitivity Completed Imperial College London N/A 2006-07-01 The purpose of this study is to conduct a randomised trial to compare the insulin sensitivity, 24 hour blood pressure profile, and tolerability of nebivolol plus a thiazide-like diuretic versus atenolol plus a thiazide-like diuretic.
NCT00142584 ↗ Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension Completed Mylan Bertek Pharmaceuticals Phase 3 2005-08-01 The purpose of this study is to evaluate long-term safety,tolerability and blood pressure effects of metoprolol versus nebivolol in patients with hypertension. These drugs may be given alone or in combination with other drugs that are commonly used in the treatment of hypertension
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nebivolol Hydrochloride

Condition Name

Condition Name for Nebivolol Hydrochloride
Intervention Trials
Hypertension 55
Heart Failure 7
Heart Failure With Preserved Ejection Fraction 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Nebivolol Hydrochloride
Intervention Trials
Hypertension 59
Heart Failure 9
Ventricular Dysfunction, Left 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Nebivolol Hydrochloride

Trials by Country

Trials by Country for Nebivolol Hydrochloride
Location Trials
United States 321
Italy 5
Korea, Republic of 5
Puerto Rico 3
Denmark 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Nebivolol Hydrochloride
Location Trials
Texas 17
Florida 17
California 16
Georgia 14
New York 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Nebivolol Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Nebivolol Hydrochloride
Clinical Trial Phase Trials
Phase 4 45
Phase 3 18
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Nebivolol Hydrochloride
Clinical Trial Phase Trials
Completed 68
Unknown status 7
Terminated 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Nebivolol Hydrochloride

Sponsor Name

Sponsor Name for Nebivolol Hydrochloride
Sponsor Trials
Forest Laboratories 39
Mylan Bertek Pharmaceuticals 9
Menarini Group 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Nebivolol Hydrochloride
Sponsor Trials
Other 110
Industry 65
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Johnson and Johnson
Medtronic
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.